Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
SNTI on Nasdaq
Shares outstanding
30,025,160
Price per share
$1.05
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
5,609,415
Total reported value
$7,909,282
% of total 13F portfolios
0%
Share change
-1,256,651
Value change
-$2,933,647
Number of holders
15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Celadon Partners SPV 24 45% 0% $14,186,888 +$112,225 13,511,322 +0.8% Celadon Partners SPV 24 19 Jan 2026
New Enterprise Associates 15, L.P. 14% $12,232,993 3,775,615 New Enterprise Associates 15, L.P. 06 Mar 2025
Nantahala Capital Management, LLC 8.1% -19% $7,192,800 +$5,542,723 2,220,000 +336% Nantahala Capital Management, LLC 31 Mar 2025
ARMISTICE CAPITAL, LLC 5% -50% $4,664,991 +$2,928,318 1,439,812 +169% Armistice Capital, LLC 31 Mar 2025
Nantahala Capital Partners Limited Partnership 1.9% -67% $1,628,100 +$651,240 502,500 +67% NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 31 Mar 2025

As of 30 Sep 2025, 15 institutional investors reported holding 5,609,415 shares of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI). This represents 19% of the company’s total 30,025,160 outstanding shares.

Top 20 Institutional Shareholders

The largest institutional shareholders of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) together control 19% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
NEA Management Company, LLC 13% 3,775,615 0% 0.29% $5,323,617
Nantahala Capital Management, LLC 3% 888,000 0% 0.08% $1,252,080
VANGUARD GROUP INC 2.1% 616,073 +71% 0% $868,663
GEODE CAPITAL MANAGEMENT, LLC 0.51% 152,838 +3.7% 0% $215,509
CITADEL ADVISORS LLC 0.28% 82,753 0% $116,682
XTX Topco Ltd 0.09% 26,567 0% $37,459
BlackRock, Inc. 0.08% 22,604 +2.4% 0% $31,872
NORTHERN TRUST CORP 0.05% 16,310 0% $22,997
TWO SIGMA INVESTMENTS, LP 0.05% 15,968 0% $22,515
STATE STREET CORP 0.03% 10,010 0% 0% $14,114
Tower Research Capital LLC (TRC) 0.01% 1,730 +54% 0% $2,439
BANK OF AMERICA CORP /DE/ 0% 450 -19% 0% $634
SBI Securities Co., Ltd. 0% 336 -0.59% 0% $474
MORGAN STANLEY 0% 160 0% 0% $226
CITIGROUP INC 0% 1 0% $1
UBS Group AG 0% 0 -100% $0
BARCLAYS PLC 0% 0 -100% $0
ARMISTICE CAPITAL, LLC 0% 0 -100% $0
HEIGHTS CAPITAL MANAGEMENT, INC 0% 0 -100% $0
HEIGHTS CAPITAL MANAGEMENT, INC 0% 0 -100% $0

Institutional Holders of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 5,609,415 $7,909,282 -$2,933,647 $1.41 15
2025 Q2 6,484,682 $13,682,488 +$1,724,639 $2.11 14
2025 Q1 5,663,433 $19,029,155 +$16,777,530 $3.36 14
2024 Q4 667,184 $2,341,958 -$330,209 $3.51 14
2024 Q3 763,984 $1,726,485 +$1,717,435 $2.26 12